Top Growth Stocks to Buy in October 2026: Amazon, AbbVie, Netflix

As the S&P 500 continues to reach record highs, investors are faced with the challenge of finding well-valued growth stocks. With valuations rising, it is crucial to focus not just on growth potential but also on strong underlying fundamentals to avoid vulnerabilities in case of market corrections. Among the top picks for October 2026 are Amazon (AMZN), AbbVie (ABBV), and Netflix (NFLX).

Amazon, despite its $2.8 trillion market cap and leading position in the tech sector, has seen its shares rise just 11% this year, lagging behind the S&P 500's 14% gain. Its price-to-earnings (P/E) ratio stands at 20, which is relatively low compared to its past premium valuations. The company is heavily investing in artificial intelligence (AI), developing its own chips, and expanding its robotaxi business through Zoox. Analysts suggest that Amazon's current valuation does not fully reflect its growth prospects, making it a compelling buy.

AbbVie, a major player in the healthcare sector, offers diversification and adaptability. While concerns about patent expirations on Humira have arisen in the past, the company has successfully offset revenue losses with its drugs Rinvoq and Skyrizi. AbbVie's acquisition strategy has impacted its earnings, making its trailing P/E multiple appear high at 75. However, its forward P/E multiple is just 16, indicating a more attractive valuation compared to the S&P 500's average forward P/E of 20.

Netflix, down 27% this year, presents another attractive opportunity. Despite market uncertainties and concerns about customer engagement, the company's revenue grew by 13% in its most recent quarter, with projections of $51 billion for the full year. Netflix's valuation at 22 times trailing earnings and a forward P/E of 19 suggests it is undervalued, making it a strong contender for growth-oriented investors.